AVENUE THERAPEUTICS, INC.
AVENUE THERAPEUTICS, INC. (ATXI) is a publicly traded company in the Unknown sector. Across all available filings, 16 corporate insiders have executed 79 transactions totaling $4.6M, demonstrating a bearish sentiment with -$1.8M in net insider flow. The most recent transaction on Sep 23, 2024 involved a transaction of 65,000 shares valued at $0.
ATXI Insider Activity Summary
Who Is Buying ATXI Stock?
No significant insider buying has been recorded for ATXI in the recent period.
Who Is Selling ATXI Stock?
No significant insider selling has been recorded for ATXI in the recent period.
Is AVENUE THERAPEUTICS, INC. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ATXI is bearish with an Insider Alignment Score of 30/100 and a net flow of -$1.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
ATXI Frequently Asked Questions
Understanding ATXI Insider Activity
Insider trading at AVENUE THERAPEUTICS, INC. (ATXI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 16 insiders are actively trading ATXI stock, having executed 79 transactions in the past 90 days. The most active insider is Pharmaceuticals, Inc. Invagen (Executive), who has made 1 transactions totaling $3.0M.
Related Tools
Track AVENUE THERAPEUTICS, INC. Insider Activity
Get notified when executives and directors at ATXI file new Form 4 transactions